https://de.marketscreener.com/kurs/aktie/REZOLUTE-INC-114862310/news/Rezolute-Inc-kundigt-den-Beginn-einer-Phase-2-Studie-mit-Rz402-bei-Patienten-mit-diabetischem-Mak-42563051/?utm_source=telegram&utm_medium=social&utm_campaign=share